PSAT243 Late Versus Early Administration of Radioiodine Therapy for Patients with Differentiated Thyroid Cancer: A Systematic Review and Meta-analysis

BACKGROUND: Radioiodine (RAI) therapy is an important adjuvant therapy for differentiated thyroid carcinoma (DTC) patients. Several studies have demonstrated the efficacy of RAI in reducing the risk of thyroid cancer recurrence and mortality; however, the ideal timing to initiate RAI after surgery i...

Descripción completa

Detalles Bibliográficos
Autores principales: Lincango Naranjo, Eddy P, Mora, Samantha, Intriago-Baldeón, Dãmaris P, Acosta, William, Leal-Medina, Ivelin, Dueñas-Andrade, Sarahí, Ledesma-León, Tannya, Valle, Camila, Dominguez, Carla M, Ayala, Andres, Ponce, Oscar J, Brito, Juan P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Thyroid
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625308/
http://dx.doi.org/10.1210/jendso/bvac150.1665

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625308/
http://dx.doi.org/10.1210/jendso/bvac150.1665

Ejemplares similares